Cas:14422-50-5 5-chloro-2-[(2-chloroacetyl)amino]benzoic acid manufacturer & supplier

We serve Chemical Name:5-chloro-2-[(2-chloroacetyl)amino]benzoic acid CAS:14422-50-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-chloro-2-[(2-chloroacetyl)amino]benzoic acid

Chemical Name:5-chloro-2-[(2-chloroacetyl)amino]benzoic acid
CAS.NO:14422-50-5
Synonyms:2-Chloracetamido-5-chlorbenzoesaeure;N-chloroacetyl-5-chloroanthranilic acid;1-Chloro-2-(2-carboxy-4-chlorophenyl)amino-2-oxoethane;5-Chlor-2-chlor-acetamino-benzoesaeure;5-chloro-2-[(chloroacetyl)amino]benzoic acid;5-chloro-N-(2-chloroacetyl)anthranilic acid
Molecular Formula:C9H7Cl2NO3
Molecular Weight:248.06300
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:69.89000
Exact Mass:246.98000
LogP:2.86500

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Chloracetamido-5-chlorbenzoesaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-N-(2-chloroacetyl)anthranilic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-N-(2-chloroacetyl)anthranilic acid Use and application,5-Chlor-2-chlor-acetamino-benzoesaeure technical grade,usp/ep/jp grade.


Related News: With no new systemic lupus erythematosus treatments in over a decade, we’re working to make this new medicine available as soon as possible.” 2-(2-methylimidazol-1-yl)aniline manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. Oritavancin Diphosphate suppliers As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.” (4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol vendor & factory.